Editorial
 LAST DEADLINE FOR IPDMS   
 Wednesday, February 10, 2016 
 The National Pharmaceutical Pricing Authority in collaboration with the National Informatics Centre developed an Ingredient Pharmaceutical Database Management System in September 2014 aimed at facilitating on-line submission of mandatory returns/reports under the DPCO 2013 by the pharmaceutical companies. 
  Past Editorial...  
TODAY'S NEWS
17:00  [IST]Silicon Biosystems, Swift Biosciences partner to unlock genomic information from FFPE samples
16:40  [IST]IPA with ACG Worldwide & SciTech calls for entries of awards
16:35  [IST]Alkem Laboratories net jumps by 17% to Rs. 189 cr in Q3
16:20  [IST]Higher other income, lower interest and tax burden push Sun Pharma net profit to Rs.1,417 cr in Q3
16:00  [IST]Cidara's antifungal drug, CD101 IV receives US FDA orphan drug status
15:10  [IST]BLK Super Speciality Hospital first to install ECP in India
more news >>
TOP NEWS
08:00  [IST]PhRMA concerned over Sect 3(d) of India’s Patents Act as it fears other emerging markets may emulate it as a model
08:00  [IST]IPC, IMA to come out with guidance document for community pharmacists to strengthen their role in PvPI
08:00  [IST]Siddha practitioners from other states to form new body, ISMGA likely to split
08:00  [IST]Telangana govt move to register all small hospitals,nursing homes opposed by THANA
08:00  [IST]8th edition of Bangalore India Nano to be held from March 3-5, 2016
08:00  [IST]MSF supports people living with HIV to oppose Viiv’s attempt to get patents for HIV drugs dolutegravir & cabotegravir
more news >>
YESTERDAY'S NEWS
16:50  [IST]BSE Healthcare index sinks by 393 points in line with other sectoral indices
15:55  [IST]EcronAcunova wins Bio-Excellence Award at Bangalore India Bio 2016
15:50  [IST]Union minister Dr. Harsh Vardhan inaugurates Translational Research Unit of Excellence in Kolkata
15:35  [IST]SRL Diagnostics introduces technique in India to diagnose fibrosis
15:30  [IST]Mylan to buy Meda for US$ 9.9 billion
14:50  [IST]Stem cell sector sees need for regulations to be simplified and approval process to be seamless
more news >>
INTERVIEW  
IDMA taking steps to strengthen and tap biz opportunities for SMEs
S.V. Veerramani, the new president of the Indian Drugs Manufacturers Association (IDMA)
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the Union Health Ministry's move to hike licence fee for medical shop from the existing Rs 3000 to Rs 30,000 justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2015 Saffron Media Pvt. Ltd |